明德生物：首期3570.10万元增资并收购湖南蓝怡51%股权

Group 1 - The company announced the acquisition of a 51% stake in Hunan Lanyi from Blue Yi Group for 35.71 million yuan, which will be completed by January 19, 2026 [1] - After the acquisition, Hunan Lanyi will become a subsidiary of the company and will be included in the consolidated financial statements [1] - The company's investment in Hunan Lanyi amounts to 7.854 million yuan, representing a 51% ownership stake, while Blue Yi Group and Jiashan Hexin hold 29% and 20% respectively [1] Group 2 - The company plans to further acquire the remaining equity of Hunan Lanyi if the company meets the agreed operational conditions between 2026 and 2028 [1]